Literature DB >> 3487701

The dual role of lymphocytic choriomeningitis virus-specific antibodies.

A R Thomsen, O Marker, M Volkert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487701     DOI: 10.1007/BF02122430

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  6 in total

1.  The activity of T and B lymphocytes in immunity and tolerance to the lymphocytic choriomeningitis virus in mice.

Authors:  M Volkert; K Bro-Jorgensen; O Marker; B Rubin; L Trier
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

Review 2.  The interplay between lymphocytic choriomeningitis virus, immune function, and hemopoiesis in mice.

Authors:  K Bro-Jørgensen
Journal:  Adv Virus Res       Date:  1978       Impact factor: 9.937

3.  Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice.

Authors:  M B Oldstone; F J Dixon
Journal:  Science       Date:  1967-12-01       Impact factor: 47.728

Review 4.  The virology and immunobiology of lymphocytic choriomeningitis virus infection.

Authors:  M J Buchmeier; R M Welsh; F J Dutko; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

5.  Different isotype profiles of virus-specific antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice.

Authors:  A R Thomsen; M Volkert; O Marker
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

6.  Virus-induced immune complex disease: genetic control of C1q binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus.

Authors:  M B Oldstone; A Tishon; M J Buchmeier
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

  6 in total
  1 in total

1.  Early life vaccination: Generation of adult-quality memory CD8+ T cells in infant mice using non-replicating adenoviral vectors.

Authors:  Loulieta Nazerai; Maria R Bassi; Ida E M Uddback; Peter J Holst; Jan P Christensen; Allan R Thomsen
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.